PMID- 23608221 OWN - NLM STAT- MEDLINE DCOM- 20130731 LR - 20191210 IS - 1479-6805 (Electronic) IS - 0022-0795 (Linking) VI - 218 IP - 1 DP - 2013 Jul TI - Multiple signaling pathways mediate ghrelin-induced proliferation of hippocampal neural stem cells. PG - 49-59 LID - 10.1530/JOE-13-0045 [doi] AB - Ghrelin, an endogenous ligand for the GH secretagogue receptor (GHS-R) receptor 1a (GHS-R1a), has been implicated in several physiologic processes involving the hippocampus. The aim of this study was to investigate the molecular mechanisms of ghrelin-stimulated neurogenesis using cultured adult rat hippocampal neural stem cells (NSCs). The expression of GHS-R1a was detected in hippocampal NSCs, as assessed by western blot analysis and immunocytochemistry. Ghrelin treatment increased the proliferation of cultured hippocampal NSCs assessed by BrdU incorporation. The exposure of cells to the receptor-specific antagonist d-Lys-3-GHRP-6 abolished the proliferative effect of ghrelin. By contrast, ghrelin showed no significant effect on cell differentiation. The expression of GHS-R1a was significantly increased by ghrelin treatment. The analysis of signaling pathways showed that ghrelin caused rapid activation of ERK1/2 and Akt, which were blocked by the GHS-R1a antagonist. In addition, ghrelin stimulated the phosphorylation of Akt downstream effectors, such as glycogen synthase kinase (GSK)-3beta, mammalian target of rapamycin (mTOR), and p70(S6K). The activation of STAT3 was also caused by ghrelin treatment. Furthermore, pretreatment of cells with specific inhibitors of MEK/ERK1/2, phosphatidylinositol-3-kinase (PI3K)/Akt, mTOR, and Jak2/STAT3 attenuated ghrelin-induced cell proliferation. Taken together, our results support a role for ghrelin in adult hippocampal neurogenesis and suggest the involvement of the ERK1/2, PI3K/Akt, and STAT3 signaling pathways in the mediation of the actions of ghrelin on neurogenesis. Our data also suggest that PI3K/Akt-mediated inactivation of GSK-3beta and activation of mTOR/p70(S6K) contribute to the proliferative effect of ghrelin. FAU - Chung, Hyunju AU - Chung H AD - Department of Core Research Laboratory, Clinical Research Institute, Kyung Hee University Hospital at Gangdong, Seoul, Korea. FAU - Li, Endan AU - Li E FAU - Kim, Yumi AU - Kim Y FAU - Kim, Sehee AU - Kim S FAU - Park, Seungjoon AU - Park S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130601 PL - England TA - J Endocrinol JT - The Journal of endocrinology JID - 0375363 RN - 0 (Enzyme Inhibitors) RN - 0 (Ghrelin) RN - 0 (Ghsr1a protein, rat) RN - 0 (Hormone Antagonists) RN - 0 (Phosphoinositide-3 Kinase Inhibitors) RN - 0 (Receptors, Ghrelin) RN - 0 (Recombinant Proteins) RN - 0 (STAT3 Transcription Factor) RN - 0 (Stat3 protein, rat) RN - EC 2.7.1.137 (Phosphatidylinositol 3-Kinase) SB - IM MH - Adult Stem Cells/cytology/drug effects/*metabolism MH - Animals MH - Cell Proliferation/drug effects MH - Cells, Cultured MH - Enzyme Inhibitors/pharmacology MH - Ghrelin/antagonists & inhibitors/genetics/*metabolism MH - Hippocampus/cytology/drug effects/*metabolism MH - Hormone Antagonists/pharmacology MH - MAP Kinase Signaling System/drug effects MH - Neural Stem Cells/cytology/drug effects/*metabolism MH - *Neurogenesis/drug effects MH - Phosphatidylinositol 3-Kinase/metabolism MH - Phosphoinositide-3 Kinase Inhibitors MH - Phosphorylation/drug effects MH - Protein Processing, Post-Translational/drug effects MH - Rats MH - Rats, Inbred F344 MH - Receptors, Ghrelin/antagonists & inhibitors/biosynthesis/*metabolism MH - Recombinant Proteins/antagonists & inhibitors/metabolism MH - STAT3 Transcription Factor/antagonists & inhibitors/metabolism MH - *Signal Transduction/drug effects MH - Up-Regulation/drug effects OTO - NOTNLM OT - ghrelin OT - hippocampus OT - progenitor OT - proliferation OT - signaling pathways EDAT- 2013/04/24 06:00 MHDA- 2013/08/01 06:00 CRDT- 2013/04/24 06:00 PHST- 2013/04/24 06:00 [entrez] PHST- 2013/04/24 06:00 [pubmed] PHST- 2013/08/01 06:00 [medline] AID - JOE-13-0045 [pii] AID - 10.1530/JOE-13-0045 [doi] PST - epublish SO - J Endocrinol. 2013 Jun 1;218(1):49-59. doi: 10.1530/JOE-13-0045. Print 2013 Jul.